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Abstract 
A major risk from exposure to space radiation is the induction of cancer and it is from estimates of 
this risk that the maximum career flight times of NASA space crew members are restricted by a 
permissible exposure limit.  For the purpose of demonstrating compliance with the career limit, 
NASA has developed a cancer risk projection model for exposure-induced fatal cancer, in which the 
formulation and numerical values of the quality factor (QFNASA) are substantially different from those 
of the quality factor (Q) or radiation weighting factor (wR) routinely applied for radiation protection 
on earth.  The quality factor is used to account for the increased effectiveness of radiations of high 
linear energy transfer (LET), compared to the effectiveness of low-LET γ-rays derived from 
epidemiological studies of the atomic-bomb survivors.   The need for a special approach for space 
radiation is dictated by the special characteristics of the charged particles from solar radiation and 
especially the charged particles of high energy and charge (HZE) in galactic cosmic rays (GCR).  This 
article considers aspects of radiation track structure in relation to the relative biological effectiveness 
(RBE) of HZE particles and the quality factor used for space radiation. The NASA quality factor 
(QFNASA) is composed of two terms, which can be interpreted as broadly representing the low- and the 
high-ionization-density components of the HZE particle tracks. These are discussed in turn as they 
relate to available experimental evidence on the biological effectiveness of such components.  Also 
briefly described are subsequent published proposals for a reformulation of the quality factor to relate 
more directly to the acute γ-ray exposures from the atomic bombs and for further refinement of the 
parameter values (and their uncertainties) that determine the shape of the quality factor function.  
Other recent developments are also mentioned. 
  
1. Introduction 
Crew members in space are exposed to a unique and complex radiation environment. In order 
to estimate the risks to the health of the crew, and to comply with safety standards for acceptable 
career risks, detailed consideration needs to be given to the types of charged particles encountered  in 
space and the nature of the tracks of ionizations that they produce as they pass through tissue.  These 
track structures are greatly different from those commonly encountered on earth.  Risk models require 
quality factors to account for these differences by relating them to the relatively well-established risk 
coefficients for human exposures to photons on earth.  The quality factor developed by NASA, for use 
in its cancer risk projection model, incorporates a formula that relates to densely- and sparsely-
ionizing components of the radiation tracks.  The parameters of the formula have been selected with 
guidance from experimental data from animal tumors, where possible, and from chromosome 
aberrations and other effects on cells irradiated in culture.   Ongoing research leads to suggestions for 
future refinement of these parameters as more experimental data become available and also leads to 
possible modifications to the formula to reduce uncertainties.  At present, uncertainty in the values of 
quality factor is the largest component of uncertainty in assessing the cancer risks from space 
radiation and this constrains the career limit for the time that NASA crew can spend in space 
(Cucinotta et al. 2013, 2015). 
https://ntrs.nasa.gov/search.jsp?R=20180006105 2019-08-31T15:08:07+00:00Z
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The space radiation environment background has three major components of relevance to 
exposure of space crew: galactic cosmic radiation (GCR), solar particle events (SPEs), and trapped 
radiation belts (Schimmerling 2011; NCRP 2014).  GCR, which is the component of major concern in 
deep space beyond the protection of the earth’s magnetic field, are mostly highly energetic and 
composed of all naturally occurring elements; there is a high proportion of protons and helium ions, 
but elements as heavy as iron are also of concern.  SPE consist mostly of protons of moderate energies 
and occur sporadically with frequencies dependent on the solar cycle and with intensities that vary 
widely and are not predictable; they are moderately shielded by the material of spacecraft but can be 
of particular concern during extravehicular activities.  Trapped radiation consists of lower energy 
protons and electrons, which in low earth orbit are mostly shielded by the material of spacecraft.  In 
addition, space crew are exposed to the secondary radiation that is produced when the primary SPE 
and GCR interact with the spacecraft materials and within the human body. 
It is well established that ionizing radiations can cause cancer and other deleterious health 
effects and that, in general, radiations of high linear-energy transfer (LET)1 are more biologically 
damaging per unit absorbed dose2 than are low-LET radiations.  The complex radiation exposure of 
crew members in space has a substantial high-LET component due to the heavy charged particles in 
GCR, SPE and the secondary particles which they produce by interactions with the spacecraft and the 
body.  Space permissible exposure limit (SPEL) standards have been set by NASA in order to protect 
crew members from unacceptable risks from their space exposures (NASA 2015). With respect to 
cancer, the SPELs require that planned career exposure for radiation shall not exceed 3% risk of 
radiation exposure induced death (REID), adjusted for age and sex. The risk limit must be met at a 
95% confidence level.  In order to evaluate the best estimate of REID and its uncertainty distribution, 
NASA has developed a cancer risk projection model for exposure-induced fatal cancer (Cucinotta et 
al. 2013) and it is on this basis that the career limit of days in space for individual crew members is 
determined from their exposure histories.  The NASA cancer risk projection model is specifically 
designed to take into account the unique nature of space radiation, which produces particle tracks of 
great complexity and diversity.   
2. Radiation tracks in space and on earth 
The solar particles and GCR encountered in space, and their secondary radiations, result in 
track structures of great diversity as the charged particles pass through the tissue of space crew. These 
tracks differ greatly from the tracks produces by common radiations on earth.  Figure 1 illustrates 
short segments of tracks from a selection of such space radiation particles.  For these examples, the 
tracks have been generated by the Monte-Carlo track structure simulation code RITRACKS (Plante 
and Cucinotta 2008; Toburen 2014); they show the high density of ionizations and excitations along 
the path of the primary charged particle as it interacts with molecules along its path and, also, high 
density very close to the path due to the overlapping tracks of the lowest-energy delta-ray electrons.  
At greater distances from the path of the heavy particle average ionization densities decrease 
progressively due to the stochastic array of higher-energy delta-ray electrons also set in motion by the 
primary particle.  These delta-rays can sometimes extend out to very large distances, depending on the 
                                                          
1 The linear energy transfer (LET) for charged particles of a given type and energy in a given material, is the 
quotient of the mean energy lost by the charged particles due to electronic interactions in traversing a unit 
track length. The unit often used for LET is keV μm−1. 
2 The fundamental dose quantity is absorbed dose, D, defined as the quotient of dε by dm, where dε is the 
mean energy imparted by ionizing radiation to matter of mass dm. The SI unit is J kg-1 and is given the special 
name gray (Gy). 
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velocity of the primary particle, even out to more than about a centimeter for particles of specific 
energy greater than 1000 MeV/u.  The LET of heavy charged particles is given by the Bethe-Bloch 
stopping power formula3 (Alloni et al. 2014), which shows that the LET increases approximately as 
the square of the ion charge, Z, and the inverse square of its velocity, V.  On the other hand, the 
maximum range of the delta-ray electrons depends on the velocity of the particle but not its charge.  
Hence specification of the LET of a particle is seriously inadequate as a description of its track 
structure; two particles of identical LET but very different charge and velocity will have very different 
track structures. 
 
 
Figure 1: Examples of central portions of track segments from a selection of heavy particles in liquid 
water.  In each case, the specific energy and the LET of the particle is marked.  Each track segment shown 
is about 16 µm in length and the sides of the track are cut off at about 7 µm from the track center; many of 
the delta-ray electrons travel to much greater distances.  The two upper left panels are for identical 
particles and thereby illustrate the stochastic variation in individual structures. The values marked P(Z,E) 
represent the average proportion of energy deposited by the particle track that acts in a high-ionization-
density manner (evaluated from equations (3) and (4) below).  The values marked Qhi represent the 
percentage of QFNASA that is due to the high-ionization-density component, QHi, in equation (5) below for 
solid cancer risk.  See Section 4 below for further explanations.  Tracks were generated by the RITRACK 
Monte Carlo code (Plante and Cucinotta 2008).  
                                                          
3  The Bethe-Bloch stopping power formula can be written as  
dE/dℓ = 2πNAre2mec2ρ(z/A)(Z2/β2)[ln(2meγ2v2WM/I2) - 2β2 – 2S/z – δ], 
where Z = charge of the incident particle in units of electron charge; β = v/c, v being the velocity of the particle 
and c is the velocity of light; WM = maximum energy transfer in a single collision; re = classical electron radius; 
NA = Avogadro’s number; I = mean excitation potential; me = electron rest mass; z, A, ρ = atomic number, 
atomic weight and density of material, respectively; γ = 1/(1-β2)2/3; S = shell factor correction; and δ = density 
effect correction. 
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 The above HZE radiation tracks encountered in space are greatly different from those 
experienced on earth.  In dramatic contrast, an X- or γ-ray photon such as encountered on earth 
produces only a single primary electron when it interacts in tissue by Compton scattering or the 
photo-electric interaction or, at most, a pair of electrons by pair production. Therefore the track 
structures from photon exposures are simply those of individual electrons, including the lower-energy 
secondary electrons that are set in motion as the electrons interact and slow down (illustrated in 
Figures 2a and b). Overall X- and γ-rays are sparsely ionizing and are classified as low-LET radiation.  
On the other hand, the most densely-ionizing radiation normally encountered on earth is alpha-
particles from radionuclide decays. Due to their low energy, however, such alpha particles travel only 
very short distances (< 0.1 mm in tissue), and so are a health hazard only when the radionuclides are 
internalized in the body; their delta-ray electrons extend out only to a fraction of a micrometer.  
Therefore, although these alpha particles are high-LET radiation (~ 60 – 230 keV/µm), their track 
structures are vastly different from HZE of similarly high LET.  LET alone is an inadequate 
description of radiation quality because it provides only an average one-dimensional description of the 
ionization density; it ignores the radial distribution of ionizations due to the delta-ray electrons and 
also the stochastic variability (Curtis 2016). 
 
 
Figure 2a.  Schematic diagram of two tracks of electrons from γ-ray interactions (upper portion) or of 
two low-energy alpha particles from radionuclide decay (lower part) passing through a cell nucleus of 
diameter 8 µm. (Adapted from Goodhead 1994.) 
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Figure 2b.  Schematic diagram at higher magnification of two tracks of electrons (upper portion) or of 
one low-energy alpha particles (lower part) passing through DNA and chromatin.  (Adapted from 
Goodhead 1988.) 
 
3. Health risks, RBE and quality factor 
 There is a general paucity of human epidemiological data on the health risks of exposures to 
high-LET heavy charged particles, due mainly to the small numbers of people who have been exposed 
to significant quantities of such radiations, with the notable exception of low-energy short-ranged 
alpha-particles in the lung from inhalation of environmental radon and its short-lived decay products.  
Other less-common high-LET exposures, such as from other internal alpha-emitters or external 
neutrons in some occupational situations, from carbon ions as a recent modality of radiotherapy or to 
astronauts from cosmic-rays, have to date been insufficient in number and uniformity to provide a 
meaningful database for estimation of cancer risks.  There are no statistically significant epidemiology 
data for late effects from GCR other than for eye cataracts (Chylack et al. 2009).  In contrast, there is 
a rich database of epidemiological studies of people exposed to external low-LET γ-rays and X-rays, 
particularly the survivors of the atomic bombs in Japan as well as from a wide variety of medical and 
occupational exposure situations.  Figure 3 provides a schematic representation of the type of dose 
response that might be expected for tumor induction after brief low-LET exposure and the 
corresponding expectations after high-LET exposure.  As a consequence, with few exceptions, the 
usual approach to estimating risk from high-LET radiations has been to scale the estimated low-LET 
risk coefficient per unit absorbed dose (gray) by a dimensionless factor (>1) representing the 
enhancement of effectiveness of the high-LET radiation as estimated from available evidence on the 
relative biological effectiveness4 (RBE) of the radiations from laboratory and theoretical studies.  
                                                          
4 The relative biological effectiveness (RBE) of a specified radiation is the ratio of a dose of a low-LET reference 
radiation to a dose of the radiation considered that gives an identical biological effect.  RBE values vary with 
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When the scaling is from low-LET epidemiological data of cancer risks after brief exposures at 
moderate to high doses, it is usual to introduce first a reduction factor (often known as the dose and 
dose-rate effectiveness factor, DDREF5) on the assumption that the low-LET risk coefficient is 
reduced at low doses and/or low dose rates and that the required high-LET risk is either at low doses 
or independent of dose and dose-rate over the range of interest. 
 
 
Figure 3.  Schematic representation of typical dose responses from low- and high-LET radiations, 
illustrating the slopes at low doses and the quantities RBEm, wR, and Q that are commonly used to scale 
from the low-LET slope to the high-LET slope. (Adapted from Goodhead 2009.) 
On such a basis, the rate of cancer mortality in a given tissue (T) after exposure to a given 
radiation can be written in a general form as 
λZ (DT,aE,a)  = [ λγ (aE,a) / DDREF ] . DT . RBEm   (1) 
where λγ is the rate coefficient (y-1 Gy-1) for a linear fit to the acute γ-ray exposure data from 
epidemiological studies, DT is the absorbed dose (Gy) to tissue T, ɑE is age at exposure, ɑ is attained 
age, RBEm  is the relative biological effectiveness of the given radiation at minimal dose relative to γ-
rays as reference radiation, and DDREF is the dose and dose-rate effectiveness factor.  
 In view of the paucity of epidemiological data for high-LET radiations, measurements of 
RBE in experimental systems have been used historically to guide the choice of values of RBEm to be 
                                                                                                                                                                                    
the dose, dose rate, and biological endpoint considered.  In radiological protection, the RBE for stochastic 
effects at minimal dose (RBEm) is of particular interest. 
 
5 The dose and dose-rate effectiveness factor (DDREF) is a judged factor that generalises the usually lower 
biological effectiveness (per unit of dose) of radiation exposures at low doses and low dose rates as compared 
with exposures at high doses and high dose rates. 
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used for estimating risk of stochastic effects.  Figure 4 illustrates some common features of curve 
shape of the experimental dependence of RBE on the LET of the radiation, although it should be 
emphasized that there is considerable dependence of detail also on other factors such as the biological 
effect under study (e.g. induction of particular chromosome aberrations, or of particular mutations, or 
types of tumor), the biological system in use, the level of effect or the dose (since low-LET dose-
responses are usually non-linear and high-LET response tend more towards linearity), the dose rate 
and the velocity of the charged particles of a given LET.  The latter variation in RBE at a given LET 
is the consequence of the differences in track structures between particles that have the same LET but 
different charge and velocity. 
 
 
Figure 4. Illustration of features commonly observed for the variation of relative biological effectiveness 
(RBE) with LET.  (Adapted from Goodhead 1994.) 
 For the purpose of prospective radiation protection, the International Commission on 
Radiological Protection (ICRP) has defined the dimensionless quantity radiation weighting factor, wR, 
in order to convert absorbed dose (in Gy) to equivalent dose (Sv) in a tissue and to effective dose (Sv) 
in the body (ICRP 2007).  The ICRP-specified values of wR are 1 for all photon and electron 
radiations, 2 for protons and charged pions and 20 for all alpha-particles, fission fragments and heavy 
charged particles (ICRP 2007). This simplified set of values was based on judgement from the 
available data on RBE, but with recognition of the simplicity and limited accuracy required for 
systematic application for radiation protection planning.  For operational radiation protection 
(measurements and assessment of doses in the body), a quality factor, Q, was defined as a continuous 
function of the LET of the radiation in order to give broadly similar results for measured radiation 
fields (ICRP 2007).  It is recognised that different particles of the same LET may show differences in 
RBE, but this is neglected in specifying Q as a simple function of LET because of the simplicity and 
limited accuracy required for radiation protection on earth and the small range of high of high-LET 
exposures encountered on earth. The ICRP values of wR and Q are summarized in Figure 5.  
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Additionally, the ICRP states that for the purposes of risk estimation under specific circumstances the 
best estimate of RBE for those circumstances should be used based on all available knowledge. 
 
Figure 5. Values of radiation weighting factor, wR, and quality factor, Q, in the system of radiation 
protection used on earth, as recommended by the ICRP (2007).  
It is known that particles of different charge but the same LET can induce different levels of 
response for some cancer-surrogate measureable endpoints.  Differences can be particularly large for 
the heavy charged particles encountered in space, due to the large differences in track structure that 
can exist between particles of the same LET but different charge and velocity.  Incorporation of these 
track structure features is a key conceptual difference between the quality factor used by NASA 
(QFNASA) for projection of risk from space exposures and the quality factor recommended by the ICRP 
(Q(LET)) for operational radiation protection on earth. 
 
4. NASA quality factor, QFNASA 
 Because of the unusual and diverse nature of the radiations encountered in space, especially 
the large high-LET component, a more precise analytic form of quality factor, QFNASA, has been 
developed for space radiation and applied in the NASA risk projection model for radiation exposure 
induced death from cancer (REID) (Cucinotta et al. 2013; Cucinotta 2015a).  In the NASA Cancer 
Risk Projection Model, NSCR-2012 (Cucinotta et al. 2013), when absorbed dose DT is deposited in 
tissue T, by a particle of charge Z and energy/nucleon E, equation (1) becomes 
  λZ (DT,aE,a)  = [ λγ (aE,a) / DDREF ] . DT . QFNASA   (2).  
In order to obtain REID and its uncertainty distribution for a specific scenario of space radiation 
exposure, equation (2) is summed over the particle fluence spectrum (as track segments) responsible 
for the dose to tissue T and over all tissues and the time of the exposure. 
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The NASA quality factor for particles of charge Z and energy/nucleon E is specified as  
QFNASA = [ 1 – P(Z,E) ]  +  [6.24 ( Σ0/αγ ) / LET ] . P(Z,E)   (3) 
where    P(Z,E) = (1 – exp(-Z*2/κβ2))m. (1 – e-(E/0.2)).    (4) 
β is the velocity of the particle relative to the speed of light and Z* is the effective charge6.  The 
‘height’ parameter Σ0/αγ and the so-called ‘shape’ parameters κ and m will be discussed below in 
Section 4.2. The main7 functional form of P originates from the amorphous track structure model of 
Katz et al. (1971). The NASA quality factor was reviewed by the National Academies (NA/NRC 
2012) and approved by the NASA Chief Health and Medical Officer for uses at NASA (Cucinotta 
2015a). 
Equation (3) separates the quality factor into two components, 
  QFNASA  =  QLow +  QHi       (5) 
These implicitly represent the low-ionization-density and high-ionizing-density components of the 
particle track, respectively (Cucinotta et al. 2017).  Parameter P(Z,E) can be interpreted as the 
proportion of the particle track that acts in a high-density like manner and, conversely, (1 – P) as the 
proportion that acts in a low-density like manner. The above formulation of QFNASA and its use in the 
risk-projection equation (2) implicitly assumes that the low-density component of the tracks act with 
the same effectiveness per unit absorbed dose as do the reference γ-rays. By contrast, the high-density 
component acts with weighting increased by the factor of 6.24(Σ0/αγ)/LET. The following two 
sections will discuss each of these two components in turn. 
4.1 Low-ionization-density component of QFNASA 
The low-ionization-density component in equations (3) and (5) is due to the non-overlapping 
delta-ray electrons that can be considered to act separately from the main path of the heavy charged 
particle.  In the NASA cancer risk projection model equation (2), this component is assigned the same 
biological effectiveness per unit absorbed dose as the reference γ-rays for which human cancer risk 
coefficients have been derived from epidemiological studies of the atomic-bomb survivors. How 
reasonable is this assumption in the light of comparisons between the energy spectra of the delta-ray 
electrons from HZE, on the one hand, and the primary electrons produced by the γ-ray interactions, on 
the other?  The number spectrum of delta-rays of initial energy Ee, produced by a heavy charged 
particle, falls off approximately as 1/Ee
2
, up to the maximum delta-ray energy permitted by the 
kinematics of the interaction.  Is it reasonable to expect this wide and heavily skewed spectrum of 
electron energies to act with the same biological effectiveness as the first-collision electron spectrum 
produced by interactions of the reference γ-rays? 
The value of radiation weighting factor, wR, and quality factor, Q, recommended by ICRP for 
use in radiation protection is unity for all photon and electron radiations, irrespective of energy. It is, 
however, well recognized that the relative biological effectiveness of photons and electrons does 
depend on their energy in a variety of experimental systems and is likely to do so also for human 
                                                          
6 The effective charge takes into account the reduced charge of a particle at very low specific energies (<~ 0.2 
MeV/u) due to charge exchange, using the Barkas correction. 
7 A parametric ‘thindown’ term, (1 – e-(E/0.2)), is added in equation (4) to reflect reduced biological effectiveness 
near the end of the residual range of stopping ions due to the narrowness of their tracks in this region 
(Cucinotta et al. 2013). 
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cancer induction.  It is acknowledged that the more precise values should be used for risk estimation, 
when possible.  The NCRP has recently considered the experimental, theoretical and epidemiological 
evidence for variation of RBE with photon or electron energy and from this information provided 
guidance on probability distribution functions for the effectiveness ratio for risk of human cancer 
(NCRP 2018) by photons in a variety of lower-energy bands, relative to 60Co γ-rays.  RBEs measured 
in many experimental systems are seen to increase more than two-fold as the photon energy decreases 
to very low energies.  This increase is presumably due to the increase, with decreasing photon energy, 
of the proportion of low-energy first collision electrons and the consequent increase in the proportion 
of absorbed dose deposited by very low-energy electrons (with energies of a few hundred to a few 
thousand electron-volts) in the electron slowing-down spectrum. Such very low-energy electrons have 
very short ionisation mean free paths (a few nanometers) and are particularly efficient at producing 
clustering of ionisations on the scale of the DNA helix and hence DNA double-strand breaks, both 
simple and complex (Goodhead 1994, 2009).                
As explained above, the number spectrum of delta-ray electrons from heavy charged particles 
is very heavily skewed to low energies (~1/Ee2) and the energy-weighted (or dose-weighted) spectrum 
is also skewed (~1/Ee).  On this basis alone one might expect this spectrum of electrons to be 
biologically more effective than the first collision electron spectrum from 60Co or atomic bomb γ-rays.  
However, in making such an inference, it should be borne in mind that the lowest-energy delta-ray 
tracks are entirely very close to the path of the heavy particle itself and, at least for higher-charge 
particles, are likely also to be very close to or overlapping with other delta rays.  Such delta-rays are 
likely to be partitioned by equations (3) and (4) to the high-ionisation-density component of the heavy 
particle track (as QHi in QFNASA) and thereby excluded from the present consideration of the low-
ionisation-density component.  From rough comparison of the energy spectrum of the higher-energy, 
non-overlapping, delta-ray electrons produced by heavy charged particles with the energy spectrum of 
first collision electrons from 60Co or atomic bomb γ-rays (as presented by NCRP 2018), it appears 
reasonable to suggest that the delta rays constituting the first term in equations (3) and (4) will mostly 
have similar biological effectiveness to that of the γ-rays. Particles of low charge, especially protons, 
and intermediate energies (< ~ 100 MeV/u) may deviate slightly from this general expectation 
because their very low-energy delta rays are unlikely to overlap.   
4.2 High-ionization-density component of QFNASA 
We now consider the second term in equations (3) and (5), QHi, representing the densely-
ionizing component of the heavy charged particle track. It is dependent on the charge (Z), velocity (β) 
and LET of the particle and also on the values assigned to the parameters Σ0/αγ, κ and m.  The role of 
these three fitted parameters is illustrated qualitatively in Figure 6 with respect to a notional 
relationship of quality factor versus Z*2/β2.  For simplicity of the illustration the same curve has been 
used here as previously in Figure 4 for RBE versus LET8. In practice, the same parameterized form as 
QFNASA (equation (3)) was used to fit available experimental RBE data for charged particles of 
varying velocity and charge in order to guide the choice of values of the Σ0/αγ, κ and m parameters for 
specification of QFNASA in the risk model (Cucinotta et al. 2013). 
                                                          
8 LET and Z*2/β2 are closely related because, in the Bethe-Block stopping power formula, LET is approximately 
proportional to Z2/β2, with deviations confined essentially to very low-velocity particles or to relativistic 
corrections. Plotting quality factor, or RBE, against Z*2/β2 eliminates much of the multiplicity that arises 
between particles of the same LET but different charge and velocity, as discussed by Curtis (2016) and in 
Section 5.3 of Cucinotta et al. (2013). 
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As illustrated in Figure 6, the single compound parameter, Σ0/αγ, controls the peak height of 
the quality factor curve, as illustrated in Figure 6, and is set for the estimated maximum value of 
QFNASA of the most-effective particle for induction of fatal cancer.  In practice, it is selected from fits 
to available experimental data-sets as a single parameter (Σ0/αγ), which represents the maximum effect 
cross-section of the most-effective particle normalized to the effectiveness of low dose-rate γ-ray 
exposures9.   
Regarding the two dimensionless “shape” parameters, m governs the steepness with which the 
quality factor (or RBE) curve increases with increasing Z*2/β2, and κ determines the position of the 
peak value along the Z*2/β2, axis.  For QFNASA, these too were selected from fits to available 
experimental data-sets.  
 
Figure 6.  Schematic illustration of the role of the parameters Σ0/αγ, κ and m in determining the shape of 
the RBE (or QFNASA) versus Z*2/β2 curve.  
Table 1 shows the values selected for the above three parameters for QFNASA in the current 
NASA risk projection model for risk of exposure induced death from cancer, NSCR-2012 (Cucinotta 
et al. 2013).  Different values were selected for leukemia as compared to solid cancers because the 
experimental data from animal tumor studies (as well as some human evidence) show that the RBEs 
of high-LET radiations for leukemia induction are much lower than for solid cancers in general.  
Additionally, distinct values of κ were selected for low-charge particles (Z ≤ 4).  The parameter 
values in Table 1 (and their uncertainty distributions) were set as subjective estimates from the results 
of radiobiology experiments available at the time of establishing the risk model.  The values of m 
were estimated from in vitro mammalian cell experimental data on chromosome aberrations, hprt 
mutations and neoplastic transformation, the values of κ from data on in vitro mammalian cell 
chromosome aberrations, hprt mutations and neoplastic transformation and in vivo mouse Harderian 
                                                          
9 The numerical factor 6.24/LET enters into equation (3) in association with the parameter Σ0/αγ due to 
comparison of effect cross-section (per unit fluence) for heavy particles (Σ0, in µm-2) with effect coefficient (per 
unit absorbed dose) for γ-rays (αγ, in Gy-1). 
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gland tumors, and values of Σ0/αγ from data on in vivo mouse tumors and in vitro mammalian cell 
chromosome aberrations and gene mutations (Cucinotta et al. 2013). 
                                Table 1. Parameter values for QFNASA. 
      Parameter  Solid Cancer  Leukemia  
            m    3    3 
 κ    550 (1000)*  550 (1000)* 
      Σ0/αγ, µm2Gy   7000/6.24  1750/6.24 
           * Values in parenthesis are distinct values for particles of charge ≤ 4. 
 
4.3 Evaluations of QFNASA 
 The variation of QFNASA with LET is shown in Figure 7 for a selection of heavy charged 
particles, namely hydrogen, carbon, silicon and iron, in each case separately for solid cancers and 
leukemia.  Also shown, for comparison is the corresponding ICRP quality factor, which depends only 
on LET and is independent of the particle charge (ICRP 2007).  It is readily apparent from 
comparisons across panels that there are large differences in QFNASA between particles of the same 
LET but different charge, and also large differences compared to the ICRP quality factor.  These 
features of QFNASA are a result of its approach to take into account the large differences in track 
structure, including between different particles of the same LET, and to set its parameters on the basis 
of available data on the relative effectiveness of HZE in a variety of experimental systems. 
  
 
Figure 7.  Comparison of LET dependence of QFNASA for four different charged particles (protons, 
carbon, silicon and iron) for solid cancers and for leukemias, as evaluated by the NSCR-2012 risk model 
(Cucinotta et al. 2013).  Also shown for comparison is the Q versus LET relationship recommended by 
the ICRP for operational radiation protection on earth (ICRP 2007); this is independent of particle type 
and therefore identical in each panel.  (Reproduced, with permission, from Cucinotta et al. 2013.) 
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Examples of the proportion of the energy deposited by particle tracks that acts in a high-
ionization-density manner, P(Z,E), are marked in Figure 1 for the sample of charged particles 
illustrated there (evaluated from equation (4)).   Also marked are the percentage contributions made 
by QHi to the value of QFNASA for those particles for solid cancer risk (from equations (3) and (5)).  It 
is notable how totally dominant the high-ionization-density component can be, even when a 
substantial proportion of the particles’ energy deposition is via low-ionization-density delta rays, such 
as in the case of 1000 MeV/u Fe particles.  At the other end of the extremes are, say, 1000 MeV 
protons, which produce essentially no high-ionization-density component at all (P(Z,E) = 2 x 10-9, QHi 
= (6 x 10-3)% QFNASA).  Such protons (not shown in Figure 2) produce only isolated delta-ray 
electrons, with negligible overlap in small volumes, in much the same way as do high-energy photons, 
except for the long-distance rectilinear correlation along the path of the protons.  In general, for all 
particles, the high-density component is somewhat less dominant for leukemias than it is for solid 
tumors because of the lower value assigned to Σ0/αγ (Table 1). 
The NASA space cancer risk model NSCR-2012 is used to calculate the cancer risk of 
exposure induced death (REID) at the upper 95% confidence limit (interpreted as the 97.5 percentile) 
for comparison with the space permissible exposure limit (SPEL) standards set by NASA (NASA 
2015).  For operational purposes, these calculations can be applied to evaluate the remaining mission 
duration permitted for individual space crew for a specific planned mission scenario, based on the 
crew member’s previous radiation exposure history. Therefore, a crucial aspect of the risk model is 
the probability distribution function (PDF) of REID for the particular conditions and determination of 
its 97.5 percentile.  This requires assignment of uncertainties to the parameters of the risk model, 
including those that determine the quality factor, QFNASA.  Definition of QFNASA as described above 
provides a convenient parameterized form for assignment of uncertainties, mostly in the form of 
PDFs, for the individual parameter values. In the NSCR-2012 risk model, these PDFs were assigned 
on the basis of subjective judgements from available experimental information (Cucinotta et al. 2013).  
Discussion of these uncertainty distributions is beyond the scope of the present article, but it should be 
apparent that their choice and efficiency of computation are highly pertinent to determination of the 
97.5 percentile of REID.   Recent computational research, presented as a poster at the 2017 Annual 
Meeting of the Radiation Research Society, has led to suggestions that revision of the form of the 
uncertainty distribution of the κ parameter from normal to log-normal and addition of a correlation 
constraint on the κ and m parameters leads to improved description and computational convenience of 
the high-REID tail of the risk distribution (M.R. Shavers, personal communication). 
Despite this detailed approach to defining QFNASA, quality factor remains by far the largest 
contributor to uncertainties in evaluations of REID for travel beyond low earth orbit, as illustrated in 
Table 2 for a particular mission scenario in deep space.  A major goal of current research in 
carcinogenesis by HZE is to reduce the uncertainties in QFNASA, with the expectation that this will 
increase the permitted time in space flight for space crew, sometimes described as “safe days in 
space” (Cucinotta 2015a).  In the future, NASA will report the metric “Permissible Mission 
Duration”, which is that duration of a specific mission beginning on a specific launch date for a male 
or female astronaut of a specific age that results in a projected exposure exactly equal to the NASA 
SPEL, considering the astronaut’s previous occupational exposures (M.A. Shavers, personal 
communication). 
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Table 2.  Example of contributions of various uncertainties to a probability distribution function 
for fatal cancer risk, as evaluated by the NASA risk model NSCR-2012 in Cucinotta et al. 2013.   
The point estimate is headed “Expected”. 
 
 
 
 
 
5. Proposals for further development of quality factor for space radiation 
Since the formulation of the NASA Cancer Risk Projection Model  NSCR-2012 (Cucinotta et al. 
2013) and its implementation for comparison with the space permissible exposure limit (SPEL) 
standards set by NASA (NASA 2015), ongoing research has continued to seek additional data and 
methods for potential further reduction in uncertainties in risk projection.  Sections 5.1 and 5.2 
summarize recent suggestions that relate to specification and evaluation of quality factor.  Section 5.3 
summarizes a suggestion that has been made for real-time estimation of an approximate dose-
averaged quality factor for the GCR component of exposure during a mission. 
5.1 New approach to quality factor: Qγ,acute 
 As can be seen from Table 2, another substantial source of uncertainty in the NASA risk 
projection model for REID is the value of DDREF in equation (2).  In the risk model, DDREF is 
applied to adjust the risk coefficients for low-LET exposures at high dose-rates and moderate to high 
doses, obtained from epidemiological studies such as of the A-bomb survivors in Japan, to the low 
dose rate (low fluence rate) exposures in space, before multiplication by the quality factor, QFNASA, 
for space radiation (as illustrated schematically in Figure 3).  The following alternative approach has 
subsequently been suggested (Cucinotta 2015b; Cucinotta et al., 2016).  
 If it is assumed that the first and second terms on the right-hand side of equation (3) represent 
the relative effectiveness of the low-ionization-density and the high-ionization-density parts of the 
heavy particle tracks, respectively, and that the high-density part is not dependent on dose rate, then 
the risk coefficients for this part of the tracks can be estimated by direct scaling from the coefficients 
of acute γ-ray exposures at moderate to high doses (about 0.5 – 3 Gy), without any need to invoke a 
DDREF parameter.  DDREF still needs to be employed for the low-ionization-density part of the 
track. 
 In this suggested new approach (illustrated in Figure 8), equation (2) is re-written as 
 λZ (DT,aE,a)  = λγ (aE,a). Qγ,acute . DT                     (6)  
where Qγ,acute = [ 1 – P(Z,E) ]/DDREF  +  [6.24 ( Σ0/αγ,acute ) / LET ] . P(Z,E) (7). 
[This example is for 40-y-old females on a 1-y mission at solar minimum in deep space with a 2 
g/cm2 aluminium shield.  
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As before, Σ0/αγ,acute is obtained by fitting to available data as a single parameter10, but it now sets the 
maximum effect cross-section of the most-effective particle normalized to the effectiveness of acute 
γ-ray exposures at doses in the range about 0.5 – 5 Gy.  Equation (6) is identical to equation (2) within 
the approximation that ( Σ0/αγ,acute ) ≈ ( Σ0/αγ ) /DDREF.  When this new formulation was introduced, 
the shape parameters, κ and m, were left unchanged (Cucinotta 2015b; Cucinotta et al. 2016). 
 
Figure 8.  Schematic representation of typical dose responses from low- and high-LET radiations as in 
Figure 3, but now showing the proposed direct scaling from the acute γ-ray slope at higher doses to the HZE-
particle slope, using the quality factor Qγ,acute , as compared to the scaling in the NSCR-2012 risk model, 
which uses DDREF and QFNASA. 
 This new approach to quality factor, as well as some changed methods for uncertainty 
analysis, has been incorporated as potential modifications or updates to the NSCR-2012 risk 
projection model and the modified model denoted as NSCR-2014 (Cucinotta 2015b). With the mean 
value of Σ0/αγ,acute set at 2700/6.24, evaluation of the cancer risk model for a 1-year space mission 
showed that, on their own, the changes to methods of uncertainty analysis increased predictions of 
%REID by about 35% and of the upper 95% confidence level by about 25% when compared to 
NSCR-2012, but that introduction of the new approach to quality factor, Qγ,acute (equation 6), then 
greatly reduced these higher predictions by about 40% and 50%, respectively (Cucinotta et al. 2015). 
The net effect was that NSCR-2014 predictions were about 25% and 40% lower, respectively, than 
the corresponding NSCR-2012 predictions.  Figure 9 shows such a comparison of %REID 
distributions calculated by the two models. It can be seen that both the central value and the 
uncertainties are reduced with the later model, the reduction being mainly due to the introduction of 
Qγ,acute in place of QFNASA/DDREF. 
 
                                                          
10 In the present article this new proposed parameter is given the notation Σ0/αγ,acute  to distinguish it from the 
parameter Σ0/αγ used for the original model; this distinction of notation is not made in the cited publications 
(Cucinotta 2015b; Cucinotta et al. 2016). 
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Figure 9. Comparison of probability distribution function for fatal cancer (for a specified one-year 
mission) as evaluated by the NASA risk model NSCR-2012 and the later proposed model NCSR-2014, in 
which QFNASA/DDREF is replaced by Qacute.  (Modified from Cucinotta et al. 2015.) 
5.2 Refinement of quality factor model parameter values and uncertainties 
As more experimental data on relevant biological effects of HZE become available they can 
be applied to provide further guidance for estimation of central values and uncertainty distributions of 
parameters used to define the quality factor relationship. 
It is impractical to carry out tumor induction studies in animal models for all but a small 
selection of the large number of particle types and wide range of energies in the primary and 
secondary radiations in space.  Consequently, in vitro surrogate endpoints have been used to 
investigate details of the radiation quality dependence of RBEs and it is largely on judgements from 
such data that the values of the shape parameters, κ and m, and their uncertainties were estimated for 
QFNASA for the NSCR-2012 risk projection model (see sections 4.2 and 4.3 above).  Subsequently, and 
using the same parameterized form of radiation quality dependence as in NSCR-2014 (i.e. equation 
(7)),  Cacao et al. (2016) made further systematic analyses of the best parameter values of κ and m  to 
fit in vitro data and predict RBEs of HZE exposures, particularly for induction of chromosome 
aberrations but also for cell transformation and gene induction.  Figure 10 shows how the predicted 
values of RBEacute (i.e. the RBE relative to acute γ-rays) vary with LET for a variety of heavy charged 
particles.  This diagram illustrates dramatically how substantially the RBE can differ between 
different particles of the same LET.  As stated previously, these differences are due to the large 
differences in track structure, associated particularly with the lateral spread of the energy by delta-ray 
electrons. 
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Figure 10. Predicted dependence of RBEacute on LET for a variety of charged particles and several in 
vitro biological endpoints of relevance to cancer induction.  (Reproduced, with permission, from Cacao et 
al. (2016).) 
By far the most comprehensive set of experiments on tumor induction by HZE of varying 
charge and energy was completed by Chang et al. (2016) for mouse Harderian tumors.  Figure 11 
shows the set of results, plotted as tumor prevalence versus particle traversals per cell nucleus.  
Although the Harderian gland does not exist in humans, this data-set is deemed to be particularly 
valuable because of the wide range of charged particles that were used and the consequent 
information that they can provide on the shape parameters, κ and m.  Cucinotta et al. (2017) analysed 
this dataset, to provide further guidance on the values and uncertainties of κ and m, together with the 
above results from Cacao et al. (2016) for surrogate endpoints. Estimates were then made of the value 
of the height parameter, Σ0/αγ,acute, from a wide range of mouse tumor data in the literature, including 
data that were used for development of the NSCR-2012 and NSCR-2014 risk models, but now 
extended by the later data for the Harderian tumors (Chang et al. 2016), recent results for colorectal 
and intestinal tumors (Suman et al. 2016) after HZE exposures, and results from last century for 
several tumor types induced by low-energy proton recoils from fission neutron exposures. The 
cumulative distribution function (CDF) (Figure 12) of Σ0/αγ,acute for all solid cancers gave a mean 
value of (4,728 ± 1378)/6.24. The mean value for liver cancers (13,296 ± 4739)/6.24 was much larger 
and more dispersed than for any other tumors and substantially raised the overall mean.  When liver 
cancers and Harderian11 tumors were excluded from the CDF, the mean for all the remaining solid 
cancers became (2,897 ± 357)/6.24.  The authors recommended that this latter reduced CDF be used 
for space mission risk predictions, while the more conservative estimate for liver cancer risk be 
considered in a separate calculation12 (Cucinotta et al. 2017). 
                                                          
11  Harderian gland tumors were excluded because humans do not have such a gland. 
12  The rationale for separating out liver cancers was based also on particular issues relating to extrapolation of 
liver cancer risks from the atomic bomb survivors (with very high background incidence in Japan) to the US 
population and astronauts, as well as potential large sex dependence in both the human and mouse data. 
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Figure 11. Prevalence of Harderian gland tumors in mice exposed to heavy charged particles as a 
function of particle fluence (heavy particle tracks per cell nucleus). (Modified from Chang et al. 2016).  
 
 
Figure 12.  Cumulative distribution function of parameter 6.24Σ0/αγ,acute estimated from mouse tumors  
induced by exposure to HZE and fission neutrons.  The two largest values are for hepatocellular 
carcinomas induced by HZE in male mice.  (Reproduced, with permission, from Cucinotta et al. 2017.)       
 
Revised submission to THREE 26th April 2018 
19 
 
5.3 Suggested approximation for quality factor for real-time monitoring of GCR component of 
exposure 
 When the NASA Cancer Risk Projection Model is applied to obtain REID (and its uncertainty 
distribution) for a specific scenario of space radiation exposure, equation (2) above is summed over 
the particle fluence spectrum (in terms of charge and energy of particle track segments) responsible 
for the dose to tissue T and over all tissues and the time of the exposure.  The fluence spectra are 
estimated from theoretical and experimental knowledge of the relevant space radiation environment, 
either as prospective estimates of exposure in a future mission or as retrospective estimates for a 
completed mission.  Real time evaluation during a mission is currently not practical due to the high 
demands on radiation monitoring procedures that would be required for computation of QFNASA in 
NSCR-2012.  For space exploration, the mass, volume, bandwidth and power consumption of 
dosimetry systems and particle spectrometers are highly constrained.  Therefore, it has been suggested 
that a real-time dose-averaged quality factor for GCR can be estimated by use of an alternative 
simplified formulation of quality factor based only on the LET of the particles (Borak et al. 2014).  
The proposed approximation was developed after extensive simulations using GCR distributions in 
free space, as well as the resulting spectra of primary and secondary particles behind aluminium 
shields and penetration through water.  In all cases simulated, the revised dose-averaged quality 
factors agreed well (within 5%) with those based on the corresponding values obtained using QFNASA 
(Borak et al. 2014).   
 The proposal preserves the functional form of QFNASA but replaces Z*2/β2 in equations (3) and 
(4) with LET in units of keV µm-1, as follows: 
  QN(LET) = [1 – P(LET)] + (ΣL/LET) . P(LET)                       (8) 
where P(LET) = (1 – e-LET/Ʌ)m      (9) 
The new model parameters were assigned the values shown in Table 3. 
     Table 3. Model parameter values for proposed quality factor, QN, for real-time monitoring 
        Parameter  Solid Cancer  Leukemia  
       m           3.0       3.5 
      Ʌ, keV µm-1        70                  71 
      ΣL, keV µm-1       5700     1800 
 
Borak et al. (2014) have shown that the shape of the resulting single-valued function of QN(LET) 
versus LET is similar to the major general features of the family of curves of QNASA versus LET for 
particles of individual charge, but the QN curve has a smaller peak value at a fixed value of LET for 
all particles and a broader width compared to QNASA for individual values of charge.   
When presenting the above suggestion for real-time monitoring, no attempt was made to assign 
uncertainty estimates to the individual parameter values or to the overall value of QN (Borak  et al. 
2014).  Hence, the present suggestion does not provide for evaluation of uncertainty distributions for 
the real-time contribution of the GCR exposure to REID.  Additionally, the contribution from SPE is 
not considered in this approach even though SPE can be a major source of time-varying exposure 
during a mission. 
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6. Radiation quality uncertainties not included in the cancer risk model 
 There remain issues related to track structure and radiation quality that are not considered at 
all in the quality factors as developed above. 
 The quality factor as defined by equations (3) or (7) for application in the cancer risk 
projection models NSCR-2012 or NSCR-2014, respectively, are formulated to take into account the 
increased effectiveness of HZE relative to reference γ-rays on the underlying assumption that the 
carcinogenic processes differ only quantitatively between the radiations.  However, the dramatically 
different spatial and temporal distributions in cells and tissue of the radiation interactions from HZE 
tracks compared to γ-rays, leaves ample scope also for qualitative differences in the biological 
responses.  In particular, there is some evidence for decreased latency and greater lethality of tumors 
induced by HZE particles.  This issue was recognised and discussed when the NASA cancer risk 
projection model was formulated, but it could not be included in the model because of lack of 
sufficient data for its evaluation (Cucinotta et al. 2013).  However, some estimates of the possible 
increased risks have been made (Cucinotta et al. 2015). 
 The risk models NSCR-2012 and NSCR-2014 are implicitly largely based on the assumptions 
of the conventional ‘targeted’ paradigm of radiobiology (Goodhead 2010).  In particular, they do not 
include any possible modifications of risk at low doses by non-targeted “bystander” effects.  Due to 
the low fluence rates (low dose rates) of exposure to HZE in space and the large amounts of energy 
deposition along each particle track, cells or regions of tissue are mostly exposed to single tracks, 
isolated in space and time, but each delivering a substantial dose to those cells that are directly 
traversed, as well as a much smaller dose to a larger number of additional cells within range of the 
delta-ray electrons (Curtis 2013).  Most cells in the body do not experience a direct traversal by an 
HZE particle over quite extended periods in space travel (Curtis 2016).  These circumstances of 
exposure to low fluence rates of high-LET particles may be optimal for expression of non-targeted 
effects, whereby biochemical damage signals from the traversed cells can induce effects in non-
traversed cells {Morgan and Sowa 2009; Domogauer and Azzam 2014).  There is some evidence, 
including from analyses of the shapes of dose-response in the mouse Harderian tumor data, that tumor 
induction at low doses (low fluences) of HZE particles may be enhanced by non-targeted effects; this 
mechanism could potentially increase space radiation risks by up to about 2-fold (Cucinotta and 
Cacao 2017). 
 
7. Non-cancer health risks 
 The role of track structure in relation to other health risks from space radiation is much less 
well understood than it is for cancer induction.  In order to specify dose limits to control non-cancer 
effects to the eye lens, skin, blood-forming organs and circulatory system, the NASA Space-
Permissible Exposure Limits (SPELS) use a Gray Equivalent quantity, based on RBEs specified as 
2.5 (range 1-4) for all heavy ions except for protons of > 2 MeV (RBE 1.5).  For central nervous 
system non-cancer (CNS) effects the RBE is largely unknown, so a physical dose limit in mGy is 
specified, with a lower limit being set for particles with charge Z ≥ 10 (NASA 2015).   
The role of track structure is particularly intriguing in relation to potential effects on CNS 
because of the large local energy deposition along the path of an HZE particle, the high ionization 
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density within the particle track and the substantial lateral extension of the track by delta-ray 
electrons, such that the track might overlap, for example, with much of the volume of one or more 
neurons and interact simultaneously with many components.  Monte-Carlo track structure simulations 
have been applied recently to gain insights into the types of initial damage that may occur to neuron 
cell structures from HZE particle tracks (Alp et al. 2015; 2017). 
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